FDA appoints Tracy Beth Høeg as fifth CDER head this year
Høeg’s appointment to director of CDER follows a turbulent period for the department, which recently saw the retirement of former head, Richard Padzur.
Regulation
EuropaBio calls for “bold approach to investment” amid EU Biotech Act
FDA’s revolving door reveals Pazdur as new CDER head
OS endpoint focus will realign industry to “ultimate goal”
FDA creates new pathway for rare disease drugs, analysts unconvinced
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
FDA protocol deviation guidance could go further
